MedPath

Effectiveness of Toothpaste Tablets on Plaque, Gingival Health and Caries Experiences

Not Applicable
Not yet recruiting
Conditions
Gingival Inflammation
Dental Caries
Interventions
Drug: Toothpaste Tablet
Drug: Conventional Toothpaste
Registration Number
NCT07124533
Lead Sponsor
Loma Linda University
Brief Summary

Objectives: To evaluate the effectiveness of toothpaste tablets when compared to conventional dentifrices in removing plaque.

Methods: 50 participants are randomized into two groups: Denttabs toothpaste tablets (T) and Colgate's Cavity Protection toothpaste (P). Both groups utilize their assigned dentifrice for 6 weeks. A pre and post-assessment measures the Gingival Index (GI) and Plaque Index (PI) and Decayed, Missing and Filled Teeth (DMFT). A questionnaire on the use of the product is distributed at the end of the study.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria
  1. Subjects are 18 years or older;
  2. Subjects who will comply with study protocol;
  3. Subjects who can read and understand the consent form;
  4. Subjects available during the study period;
  5. Subjects have more than 20 teeth.
Exclusion Criteria
  1. Subjects under the age of 18.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Toothpaste TabletToothpaste TabletSubjects are instructed to use one toothpaste tablet at each brushing. Brushing is recommended twice daily for two minutes.
Conventional ToothpasteConventional ToothpasteSubjects are instructed to use the toothpaste at each brushing. Brushing is recommended twice daily for two minutes.
Primary Outcome Measures
NameTimeMethod
Plaque Index Score at BaselineChange between baseline at visit 1 and visit 2, six weeks post baseline

The quantity of plaque build-up is measured visually using the Quigley-Hein Plaque Index. The Plaque index can range from 0 to 5, with higher numbers indicating more plaque build-up.

Gingival Index Score at BaselineChange between baseline at visit 1 and visit 2, six weeks post baseline

The severity of gingival inflammation is measured visually using the Loe-Silness Gingival Index. Gingival index can range from 0 to 3, with higher numbers indicating more gingival inflammation.

Secondary Outcome Measures
NameTimeMethod
DMFT Score at BaselineChange between baseline at visit 1 and visit 2, six weeks post baseline

Caries experiences is measured visually using the DMFT index. DMFT score can range from 0 to 28, with higher numbers indicating higher caries experiences.

Subject Perception of Product UseVisit 2 six weeks post study enrollment

The perception on the product usage is measured using a survey containing questions on feel, texture, flavor, ease of use, eco-friendliness, cost and overall satisfaction. Response is on a 4 point Likert scale ranging from strongly agree (1) to strongly disagree (4).

Trial Locations

Locations (2)

Loma Linda University Health

🇺🇸

Loma Linda, California, United States

Loma Linda University

🇺🇸

Loma Linda, California, United States

Loma Linda University Health
🇺🇸Loma Linda, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.